1. A novel orally administered trimebutine compound (GIC‐1001) is anti‐nociceptive and features peripheral opioid agonistic activity and Hydrogen Sulphide‐releasing capacity in mice. (6th November 2015) Authors: Cenac, N.; Castro, M.; Desormeaux, C.; Colin, P.; Sie, M.; Ranger, M.; Vergnolle, N. Journal: European journal of pain Issue: Volume 20:Number 5(2016) Page Start: 723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Internalizing behaviours in school‐age children born very preterm are predicted by neonatal pain and morphine exposure. (9th December 2013) Authors: Ranger, M.; Synnes, A.R.; Vinall, J.; Grunau, R.E. Journal: European journal of pain Issue: Volume 18:Number 6(2014) Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗